Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...

Now, let's get back to our question. Is the stock a buy or a sell? This depends a lot on your own particular investment ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1286.5 with a total volume of ...

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a handful of its pipeline programs and terminate a few others. Now, management is ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...

The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...

Moderna shares are down for the second day in a row after the company said it would slash its research and development costs.

Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.